These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14348515)

  • 1. [MECHANISMS OF THE SYNERGISM PHENOMENA OF EXPERIMENTAL SLEEP. II. STUDY OF IPRONIAZID-HYPNOTIC COMBINATIONS IN RATS AND MICE].
    BUCHEL L; LEVY J
    Arch Sci Physiol (Paris); 1965; 19():161-79. PubMed ID: 14348515
    [No Abstract]   [Full Text] [Related]  

  • 2. [INHIBITION OF MONOAMINE OXIDASE AND POTENTIATION OF EXPERIMENTAL SLEEP].
    LECHAT P; LEMEIGNAN M
    Med Exp Int J Exp Med; 1964; 10():56-66. PubMed ID: 14121410
    [No Abstract]   [Full Text] [Related]  

  • 3. [PHARMACOLOGIC STUDY OF RETURN TO SLEEP INDUCED IN THE RAT BY SUDDEN CHANGE IN ENVIRONMENTAL TEMPERATURE].
    LECHAT P; STREICHENBERGER G; MAGET E
    Med Pharmacol Exp Int J Exp Med; 1965; 13():271-7. PubMed ID: 14332764
    [No Abstract]   [Full Text] [Related]  

  • 4. [EFFECT OF IPRONIAZID, PROPAZEPINE, RESERPINE AND THEIR COMBINATIONS ON THE ORIENTATION REACTION AND CONDITIONED DEFENSE REACTION IN RATS].
    SOUSKOVA M; VOTAVA Z; ROTH Z
    Act Nerv Super (Praha); 1964; 6():258-67. PubMed ID: 14179381
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE POTENTIATION OF THE HYPNOTIC EFFECTS OF ALCOHOL AND BARBITURATES IN RABBITS BY TOLBUTAMIDE].
    KAYMAKCALAN S; TUGRUL S
    Turk Hij Tecr Biyol Derg (1961); 1964; 24():63-70. PubMed ID: 14292443
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of combinations of ataraxics with hypnotics, LSD and iproniazid in the mouse.
    ASTON R; CULLUMBINE H
    Arch Int Pharmacodyn Ther; 1960 Jun; 126():219-27. PubMed ID: 13794884
    [No Abstract]   [Full Text] [Related]  

  • 7. [A TEST FOR THE PHARMACOLOGICAL EVALUATION OF ANTIDEPRESSANTS].
    LAPIN IP
    Farmakol Toksikol; 1964; 27():498-501. PubMed ID: 14193130
    [No Abstract]   [Full Text] [Related]  

  • 8. [MECHANISM OF THE PHENOMENA OF SYNERGISM OF EXPERIMENTAL SLEEP. I. STUDY OF THE ASSOCIATIONS CHLORPROMAZINE-HEXOBARBITOL, DIHEXYVERINE-HEXOBARBITAL, IN MICE].
    BUCHEL L; LIBLAU L
    Arch Sci Physiol (Paris); 1964; 18():339-61. PubMed ID: 14251293
    [No Abstract]   [Full Text] [Related]  

  • 9. [Control of experimental peptic ulcer in rats by reserpine, tetrabenazine and iproniazid (marsilid)].
    ZBINDEN G; PLETSCHER A; STUDER A
    Schweiz Med Wochenschr; 1959 Mar; 89():289-91. PubMed ID: 13847125
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental sleep by non-barbiturate hypnotics and modifiers of hepatic microsome activity].
    Boismare F; Camacho M; Lechat P
    Therapie; 1969; 24(6):949-54. PubMed ID: 5367189
    [No Abstract]   [Full Text] [Related]  

  • 11. [GENERAL AND HYPNOTIC ACTION OF 2-METHYL-3-(O-TOLYL)-4-QUINAZOLONE AND DERIVATIVES].
    OTTAVIANO G
    Boll Soc Ital Biol Sper; 1963 Dec; 39():1768-71. PubMed ID: 14150801
    [No Abstract]   [Full Text] [Related]  

  • 12. POTENTIATION OF PARALDEHYDE HYPNOSIS BY TOLBUTAMIDE.
    MENON MM; IYER KS
    Indian J Physiol Pharmacol; 1964 Jan; 8():65-7. PubMed ID: 14248534
    [No Abstract]   [Full Text] [Related]  

  • 13. THE EFFECT OF TWO CHEMOTHERAPEUTIC AGENTS ON PARALDEHYDE AND BARBITURATE HYPNOSIS.
    IYER KS
    Indian J Physiol Pharmacol; 1964 Jan; 8():68-71. PubMed ID: 14248535
    [No Abstract]   [Full Text] [Related]  

  • 14. THE POTENTIATION OF HEXOBARBITAL HYPNOSIS BY 5-HYDROXYTRYPTAMINE.
    MAHLER DJ; HUMOLLER FL
    J Neuropsychiatr; 1964 Apr; 5():252-8. PubMed ID: 14147037
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON THE PHARMACOLOGY OF MOGADON, A HYPNOTIC WITH AN UNUSUAL ACTION MECHANISM].
    RANDALL LO; SCHALLEK W; SCHECKEL C; BAGDON RE; RIEDER J
    Schweiz Med Wochenschr; 1965 Mar; 95():334-7. PubMed ID: 14259759
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of iproniazid and raunescine on the penetration of 5-hydroxytryptamine into brain tissue from the circulation.
    KARKI NT; PAASONEN MK
    Acta Pharmacol Toxicol (Copenh); 1959; 16():20-7. PubMed ID: 14404488
    [No Abstract]   [Full Text] [Related]  

  • 17. DRUG POTENTIATION OF HYPNOTIC RESTRAINT OF RABBITS, AS INDICATED BY BEHAVIOR AND BRAIN ELECTRICAL ACTIVITY.
    KLEMM WR
    Lab Anim Care; 1965 Apr; 15():163-7. PubMed ID: 14319538
    [No Abstract]   [Full Text] [Related]  

  • 18. [APROPOS OF THE ABUSIVE USE OF ATARAXICS AND SO-CALLED TRANQUILIZING AGENTS IN EXTRAPSYCHIATRIC THERAPEUTICS].
    LABARRE J
    Ann Soc R Sci Med Nat Brux; 1963; 16():5-36. PubMed ID: 14104892
    [No Abstract]   [Full Text] [Related]  

  • 19. Polysomnography in drug development.
    Dietrich B
    J Clin Pharmacol; 1997 Jan; 37(S1):70S-78S. PubMed ID: 9048288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the mechanism of potentiation of hypnotic action of hexenal by chlorazicin].
    Vikhliaev IuI; Avakumov VM
    Farmakol Toksikol; 1966; 29(5):515-8. PubMed ID: 5997313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.